Healthcare entity

White House

organization

They are better corroborated than the beat average, carrying 5.8 original sources each against 3.6 for the same window. The clearest coverage concentration is regulation: 3 of 4 stories, with the rest divided among 1 other category. White House is most often covered alongside Artificial Intelligence, which appears in 1 of these 4 stories.

Last mentioned: Jul 14, 2026

Entity pulse

Recent coverage · White House

4 stories
7.3 avg impact
0% positive
50% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.

  • 50% neutral
  • 50% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about White House

They are better corroborated than the beat average, carrying 5.8 original sources each against 3.6 for the same window. The clearest coverage concentration is regulation: 3 of 4 stories, with the rest divided among 1 other category. White House is most often covered alongside Artificial Intelligence, which appears in 1 of these 4 stories. At 7.3, the average consequence score sits above the same-window beat average of 6. Across a 123-day span, the pace is roughly 0.2 stories per week. We currently track 4 Healthcare stories that mention White House, published between February 26, 2026 and June 28, 2026.

Stories tracked
4
Per week
0.2
Sources per story
5.8

Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 655 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering White House. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Framework Release

    White House unveils the final Comprehensive AI Governance Framework for high-stakes sectors.

  2. Public Criticism

    Major editorials highlight the FDA's 'erratic' behavior as a threat to the broader innovation ecosystem.

  3. Refusal to File

    Senior regulator Vinay Prasad refuses to review Moderna's flu vaccine application, citing trial design concerns.

  4. HHS AI Task Force

    Department of Health and Human Services forms a dedicated task force for clinical AI oversight.

  5. Grants Rescinded

    The administration pulls back hundreds of millions in funding for mRNA-based research projects.

  6. Trial Design Support

    FDA officials reportedly signal support for Moderna's flu vaccine trial workaround and data submission plan.

  7. OMB M-24-10

    Office of Management and Budget releases guidance for federal agency use of AI.

  8. Executive Order 14110

    President Biden issues the first major EO on Safe, Secure, and Trustworthy AI.

  9. Peak Valuation

    Moderna reaches a market capitalization of $200 billion during the height of pandemic vaccine distribution.

Stories mentioning White House 4

Funding Neutral

Ebola Response Gets $1.4B in $87.6B War Supplemental Request

Buried within a predominantly military funding bill, $1.4 billion is earmarked for the Central African Ebola outbreak, highlighting the Obama administration’s continued commitment to global health even as geopolitical crises dominate fiscal priorities.

16 sources

White House is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.